Bahrain FM to Asharq Al-Awsat: Relations with Israel Do Not Undermine Commitment to Peace Initiative

Bahrain’s Foreign Minister Dr. Abdul Latif al-Zayani. (Getty Images)
Bahrain’s Foreign Minister Dr. Abdul Latif al-Zayani. (Getty Images)
TT

Bahrain FM to Asharq Al-Awsat: Relations with Israel Do Not Undermine Commitment to Peace Initiative

Bahrain’s Foreign Minister Dr. Abdul Latif al-Zayani. (Getty Images)
Bahrain’s Foreign Minister Dr. Abdul Latif al-Zayani. (Getty Images)

Bahrain’s Foreign Minister Dr. Abdul Latif al-Zayani underlined on Saturday the Kingdom’s “firm and constant” stance towards the rights of the fraternal Palestinian people.

These rights top the Kingdom’s priorities, he told Asharq Al-Awsat in an exclusive interview as Bahrain announced Friday it had reached a US-brokered agreement to normalize relations with Israel.

He stressed that the deal is in line with the vision of King Hamad bin Isa al-Khalifa to spread peace in the world.

The agreement, Zayani went on to say, does not undermine the 2002 Arab peace initiative.

How do you assess the future Bahraini-Israeli relations in wake of the peace agreement?
The step is in line with King Hamad’s vision to spread the culture of peace in the world. It is also in line with his directives to intensify efforts to resolve the Palestinian-Israeli conflict according to the peace initiative. Bahrain always stresses its firm and constant position towards the rights of the fraternal Palestinian people, which are at the top of its priorities. The Palestinian people must obtain their complete legitimate rights.

Some believe, however, that normalizing ties with Israel will pave the way for other Arab concessions.
On the contrary, Bahrain stresses that it will not abandon Arab principles. Palestinian rights are the most important of these principles. Bahrain has long advocated the policy of peace and coexistence. Peace is the best strategic choice to end the Palestinian-Israeli conflict. Precedents throughout history demonstrate that all of the Kingdom’s initiatives and decisions favor the interests of the Palestinian people. No one can challenge the Kingdom in this regard.

What happens now to the Arab peace initiative after Bahrain will normalize ties with Israel?
Establishing diplomatic relations with Israel does not contradict with Bahrain’s commitment to the Arab peace initiative and international resolutions. Bahrain is a sovereign nation and it takes its decisions based on its national and Arab principles and its higher security interests. Among those principles are the Palestinian rights that cannot be abandoned.

Bahrain had from the start announced its support to the agreement between the United Arab Emirates and Israel. Was this paving the way for the peace announcement between Bahrain and Israel?
Bahrain is adding its efforts to those of the UAE in defending the causes and interests of the ummah and in supporting the Palestinians to obtain their rights. We highly appreciate the leading Emirati role in adopting diplomatic ties as a form of strategic solution to the Palestinian-Israeli conflict. For us, we underscore Bahrain’s support for all Arab partners in reaching a peaceful solution that protects the interests of all Palestinians. We believe that the declaration of peace between Bahrain and Israel creates better opportunities for the Palestinian people in establishing an independent, stable and prosperous state.

What is the Palestinian Authority’s position on the declaration of peace between Bahrain and Israel?
I want to express my great appreciation to the Palestinian leadership, its firm stances and constant efforts in safeguarding the Palestinian people’s rights and working on achieving their legitimate interests. As for Bahrain, it underlines its commitment to its efforts to empower the Palestinian people so that they can achieve their aspirations like all other peoples in the world.

Do you expect more peace agreements to be declared soon between countries in the region and Israel?
As I said before, every country has its own sovereignty and takes its decisions based on its principles and higher interests. For Bahrain, we will continue to spread the culture of peace and peaceful coexistence and shun violence. We believe this is a historic step as part of its efforts to achieve global peace. I would like to point out that countries that have established relations with Israel have not decreased their support for Palestinian rights. Strategic priorities are determined by each country to achieve their interests.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.